Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Pennsylvania for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Pennsylvania only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Pennsylvania (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Ryan Constantine (NPI 1932527199)

Field	Value
Entity Type	Individual
Organization	Ryan Constantine
Address	300 State St
City	Erie
State	PA
ZIP	16507
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	April 3, 2014

Payer Source	Total Paid
Medicare	$2M
Medicaid	$0

Key Findings

This provider’s Medicare work is heavily focused on intravitreal pharmacologic treatment and retina diagnostics: the top revenue-driving codes are J2777, J0178, and J2778, which correspond to faricimab, aflibercept, and ranibizumab injections, and the practice also reports very high volume for retinal imaging (92134). The code mix indicates a medical-retina operation centered on frequent in-office injections and monitoring rather than predominantly surgical retina practice.

Revenue concentration is extreme at the top of the fee schedule: the precomputed top 3 Medicare codes account for 80.1% of this provider’s total Medicare revenue, with J2777 and J0178 each reported as 33.3% and J2778 at 13.5% of Medicare revenue. This concentration confirms that a small set of injectable drug codes drive the majority of the $2M in Medicare receipts.

Payer mix is effectively single-payer Medicare: total Medicare revenue is $2M while there is no Medicaid billing on file, so the provider appears not to participate materially in state Medicaid billing. That absence of Medicaid activity means the business exposure and growth strategy—at least as visible in claims—are concentrated on Medicare beneficiaries.

Competitive standing on the lead drugs is mixed: J2777 (23K claims, $666.4K revenue) ranks #442 of 2039 providers (78th percentile) and is described as typical/unremarkable volume for this code, while J0178 (980 claims, $666.4K revenue) ranks #1306 of 3204 (59th percentile) and J2778 (1.5K claims, $269K revenue) ranks #296 of 1208 (76th percentile). In plain terms, the provider is not a national dominator of these injectables but is a solid, above-average participant on some agents and average on others, reflecting focused but not outsized market share.

There are clear statistical outliers in monitoring and office visit activity: 92134 appears as an "extreme outlier, far above typical national volume" (2.4K claims, $66.2K revenue, rank #741 of 26868, 97th percentile) and 99213 is "notably above typical national volume" (626 claims, $38.8K revenue, rank #17902 of 457151, 96th percentile). These elevated ranks for retinal imaging and low-complexity E/M visits suggest a high-throughput monitoring practice model that pairs frequent diagnostics with injection visits.

Surgical retina procedures are present but represent a minority of revenue: 67028 accounts for $122.9K (6.1% of Medicare revenue) with 1.4K claims and ranks #903 of 4255 (79th percentile), and other surgical codes (67108, 67036, 67041, 67042) contribute much smaller shares. This pattern indicates occasional procedural/surgical work consistent with a retina specialist who primarily treats medically with injections and performs surgery less frequently.

The provider has an established enrollment history (NPI enumerated 2014-04-03, ~12 years ago), supporting a sustained period of Medicare billing that produced the $2M lifetime Medicare revenue. Tenure combined with concentrated injectable activity and high imaging throughput suggests a mature retina practice with entrenched patterns of follow-up care and drug administration.

Operational and reimbursement implications follow from the revenue mix: with J2777 and J0178 together representing two separate 33.3% shares of Medicare revenue and the top three codes comprising 80.1% of Medicare revenue, changes in utilization patterns, reimbursement for these specific agents, or formulary access could meaningfully alter the provider’s Medicare income. The absence of Medicaid billing removes a potential diversification channel, leaving Medicare policy and drug-specific dynamics as primary external drivers of revenue.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

20 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	22,980	$30	$666.4K
J0178	Injection, aflibercept, 1 mg	980	$680	$666.4K
J2778	Injection, ranibizumab, 0.1 mg	1,470	$180	$269K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,400	$90	$122.9K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,360	$30	$66.2K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	520	$80	$41.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	630	$60	$38.8K
67108	The provider repairs a detached retina using heat produced by a laser beam or by freezing the tissues. He may attach a scleral buckle to simplify the passage of fluid through and behind the retina or…	30	$870	$27.9K
J9035	Injection, bevacizumab, 10 mg	480	$50	$25.7K
67036	The provider removes vitreous fluid from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana.	30	$670	$18.9K

Showing 1–10 of 20

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 20 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Pennsylvania Distribution

Ryan Constantine — 2 of 20 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Pennsylvania

Full comparison — all codes billed, vs. state median

20 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	24	140	830	$690	$865.1K
J2778	1	70	1,030	$190	$417.1K
J2777	5	100	7,950	$30	$360.2K
67028	12	180	600	$90	$87.5K
67042	12	50	20	$1,100	$31.9K
67041	3	10	20	$1,160	$27.8K
92014	33	1,570	130	$80	$21K
67108	3	20	20	$910	$20.1K
67036	6	30	20	$830	$19.9K
99214	2,454	23,230	100	$80	$14.5K

Showing 1–10 of 20

Related Providers

Other providers that share a Tax Identification Number (TIN) with Ryan Constantine, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Robert Baldwin	PA	Ophthalmology Physician	$2.3M	$145.9K
David Almeida	PA	Ophthalmology Physician	$1.3M	$520.5K
Kristine Traustason	OR	Ophthalmology Physician	$1.5M	$0
Douglas Babel	PA	Ophthalmology Physician	$742.6K	$63.8K
Brian Desmond	OR	Ophthalmology Physician	$257.7K	$0
Justin Pennington	MA	Ophthalmology Physician	$3.2K	$0

Nearby Providers

Other providers in the same ZIP code as Ryan Constantine, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Gaudenzia Inc	PA	Community/Behavioral Health Agency	$0	$40M
Dr Gertrude A Barber Center Inc	PA	Clinic/Center	$0	$18.7M
Laboratory Associates Of Erie LLC	PA	Clinical Medical Laboratory	$60.1K	$2.2M
Upmc Hamot Surgery Center, LLC	PA	Ambulatory Surgical Clinic/Center	$871.5K	$719.9K
Edward Zimm	PA	Ophthalmology Physician	$422.7K	$380
Ellen Dailey	PA	Obstetrics & Gynecology Physician	$72.4K	$276.7K
Paul Demjanenko	PA	Cardiovascular Disease Physician	$165.6K	$116.6K
Dimitrios Nacopoulos	PA	Neurology Physician	$250.3K	$3.5K
David Strasser	PA	Cardiovascular Disease Physician	$164.7K	$85.6K
Ajaipal Kang	PA	Plastic and Reconstructive Surgery Physician	$197.6K	$47.3K

Ryan Constantine — Billing Profile & Reimbursement Data

Sign up for Ryan Constantine — Billing Profile & Reimbursement Data policy alerts

Ryan Constantine — Billing Profile & Reimbursement Data

Sign up for Ryan Constantine — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References